SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
This Quarter Return
-4.14%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$222M
AUM Growth
+$222M
(+3.5%)
Cap. Flow
+$19.6M
Cap. Flow
% of AUM
8.81%
Top 10 Holdings %
Top 10 Hldgs %
87.78%
Holding
26
New
1
Increased
7
Reduced
9
Closed
7
Top Buys
| 1 |
QuidelOrtho
QDEL
|
$27.3M |
| 2 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$11.6M |
| 3 |
APEN
Apollo Endosurgery, Inc.
APEN
|
$3.7M |
| 4 |
Xeris Biopharma Holdings
XERS
|
$2M |
| 5 |
Evolus
EOLS
|
$1.61M |
Top Sells
| 1 |
Castle Biosciences
CSTL
|
$6.48M |
| 2 |
ADMA Biologics
ADMA
|
$4.86M |
| 3 |
Ovid Therapeutics
OVID
|
$3.58M |
| 4 |
AFMD
Affimed
AFMD
|
$2.4M |
| 5 |
DiaMedica Therapeutics
DMAC
|
$2.38M |
Sector Composition
| 1 | Healthcare | 98.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMYT
1
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $43.1M | 19.37% | 6,227,733 -70,615 | -1% | -$489K |
|
|
2
QuidelOrtho
QDEL
$1.95B
| $35.9M | 16.12% | 501,633 +381,846 | +319% | +$27.3M |
|
|
CTIC
3
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $33M | 14.83% | 5,669,388 +1,988,193 | +54% | +$11.6M |
|
|
4
Xeris Biopharma Holdings
XERS
$1.26B
| $20.2M | 9.07% | 12,928,168 +1,280,751 | +11% | +$2M |
|
|
APEN
5
DELISTED
Apollo Endosurgery, Inc.
APEN
| $15.6M | 7.02% | 2,832,631 +670,632 | +31% | +$3.7M |
|
|
6
ADMA Biologics
ADMA
$4.12B
| $12.2M | 5.46% | 5,000,000 -2,000,000 | -29% | -$4.86M |
|
7
UroGen Pharma
URGN
$900M
| $9.35M | 4.21% | 1,124,220 +13,170 | +1% | +$110K |
|
|
AMRN
8
Amarin Corp
AMRN
$311M
| $9.32M | 4.19% | 8,547,965 -305,798 | -3% | -$333K |
|
9
Ligand Pharmaceuticals
LGND
$3.15B
| $8.57M | 3.85% | 99,562 -682 | -0.7% | -$58.7K |
|
10
Rezolute
RZLT
$619M
| $8.15M | 3.66% | 2,973,205 -28,721 | -1% | -$78.7K |
|
|
OPTN
11
DELISTED
OptiNose
OPTN
| $7.32M | 3.29% | 2,000,000 -616,515 | -24% | -$2.26M |
|
|
AFMD
12
DELISTED
Affimed
AFMD
| $4.08M | 1.83% | 1,979,828 -1,163,945 | -37% | -$2.4M |
|
13
Exagen
XGN
$217M
| $3.43M | 1.54% | 1,265,373 +4,986 | +0.4% | +$13.5K |
|
|
CFMS
14
DELISTED
Conformis, Inc. Common Stock
CFMS
| $3.31M | 1.49% | 17,304,350 | – | – |
|
|
15
Ovid Therapeutics
OVID
$91M
| $2.84M | 1.27% | 1,540,671 -1,947,257 | -56% | -$3.58M |
|
|
ATYR
16
aTyr Pharma
ATYR
$527M
| $1.8M | 0.81% | 600,980 -600 | -0.1% | -$1.8K |
|
|
OPNT
17
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
| $1.64M | 0.74% | 152,278 | – | – |
|
|
18
Evolus
EOLS
$494M
| $1.61M | 0.72% | +200,000 | New | +$1.61M |
|
19
Xoma
XOMA
$392M
| $1.15M | 0.52% | 64,459 +18,549 | +40% | +$332K |
|
20
ANI Pharmaceuticals
ANIP
$2.03B
| – | – | -28,800 | Closed | -$854K |
|
21
Cidara Therapeutics
CDTX
$1.66B
| – | – | -208,443 | Closed | -$102K |
|
|
22
Castle Biosciences
CSTL
$696M
| – | – | -295,372 | Closed | -$6.48M |
|
|
23
DiaMedica Therapeutics
DMAC
$295M
| – | – | -1,176,344 | Closed | -$2.38M |
|
24
Synlogic
SYBX
$17M
| – | – | -92,746 | Closed | -$107K |
|
|
MRNS
25
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| – | – | -242,327 | Closed | -$1.17M |
|